Tweet
Bailard Inc. trimmed its position in shares of Danaher Co. (NYSE:DHR) by 5.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 68,997 shares of the conglomerate's stock after selling 3,719 shares during the period. Bailard Inc.'s holdings in Danaher were worth $6,809,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently modified their holdings of DHR. Mount Yale Investment Advisors LLC acquired a new position in Danaher during the first quarter worth $103,000. IMS Capital Management acquired a new position in shares of Danaher in the second quarter valued at $107,000. BerganKDV Wealth Management LLC acquired a new position in shares of Danaher in the second quarter valued at $111,000. Zions Bancorporation acquired a new position in shares of Danaher in the first quarter valued at $123,000. Finally, Kaizen Advisory LLC increased its holdings in shares of Danaher by 150.3% in the second quarter. Kaizen Advisory LLC now owns 1,464 shares of the conglomerate's stock valued at $144,000 after purchasing an additional 879 shares during the last quarter. Institutional investors and hedge funds own 76.33% of the company's stock. Get Danaher alerts:
DHR stock opened at $100.48 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.07 and a current ratio of 1.50. Danaher Co. has a 52 week low of $80.44 and a 52 week high of $106.08. The stock has a market capitalization of $70.21 billion, a P/E ratio of 24.93, a price-to-earnings-growth ratio of 1.92 and a beta of 1.04. Danaher (NYSE:DHR) last released its quarterly earnings results on Thursday, July 19th. The conglomerate reported $1.15 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.09 by $0.06. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The business had revenue of $4.98 billion for the quarter, compared to the consensus estimate of $4.91 billion. During the same period in the prior year, the company posted $0.99 earnings per share. Danaher's revenue was up 10.4% compared to the same quarter last year. analysts predict that Danaher Co. will post 4.49 EPS for the current year.
In related news, EVP William K. Daniel sold 103,086 shares of the company's stock in a transaction dated Friday, August 10th. The shares were sold at an average price of $100.63, for a total value of $10,373,544.18. Following the transaction, the executive vice president now directly owns 167,080 shares in the company, valued at $16,813,260.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink . Also, SVP Robert S. Lutz sold 14,555 shares of the company's stock in a transaction dated Tuesday, July 24th. The shares were sold at an average price of $103.93, for a total transaction of $1,512,701.15. Following the completion of the transaction, the senior vice president now owns 18,044 shares in the company, valued at $1,875,312.92. The disclosure for this sale can be found here . Insiders sold 299,961 shares of company stock worth $30,619,691 over the last 90 days. 11.90% of the stock is currently owned by corporate insiders.
DHR has been the topic of several research reports. Robert W. Baird reiterated a "buy" rating and issued a $106.00 price objective on shares of Danaher in a report on Friday, April 20th. Zacks Investment Research upgraded shares of Danaher from a "hold" rating to a "buy" rating and set a $113.00 price objective on the stock in a report on Thursday, May 17th. Morgan Stanley upped their price objective on shares of Danaher from $113.00 to $120.00 and gave the company an "overweight" rating in a report on Friday, July 13th. Stifel Nicolaus reiterated a "buy" rating and issued a $114.00 price objective (up from $108.00) on shares of Danaher in a report on Thursday, April 19th. Finally, Jefferies Financial Group reiterated a "buy" rating and issued a $117.00 price objective on shares of Danaher in a report on Friday, April 20th. Two investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. The stock presently has a consensus rating of "Buy" and a consensus target price of $108.31.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors